CAMBRIDGE, Ontario, Canada: Septodont, a global pharmaceutical and medical device company specializing in dental pain management, has announced that its Canada-based pharma division, Novocol Pharma, will receive funding of over C$32 million from the Canadian government. The investment is part of a countrywide initiative to advance vaccines and therapeutics for COVID-19 on a national level.
As stated in a press release, the government of Canada had made investments of approximately C$1 billion in industrial research, vaccine and pharmaceutical development, and biomanufacturing capacity by mid-March. In order to further strengthen the private sector in the fight against the global COVID-19 pandemic, it has now made new monies available via its Strategic Innovation Fund.
As announced by Septodont, the investment in Novocol will help support a C$72.6 million project to expand the company’s facilities in Ontario, and this will increase biomanufacturing capacity for fill-finish sterile injectables, including vaccines.
“By creating such capacity and capabilities, Novocol will contribute to strengthening Canada’s preparedness for future pandemics, as well as create skilled jobs and economic development in the country’s biopharmaceutical ecosystem. As a contract development and manufacturing organization, our investment will provide valuable services to support Canadian and foreign biopharmaceutical innovators, starting from clinical trial materials through to commercial scale manufacturing,” Septodont CEO Olivier Schiller commented.
According to Johns Hopkins University, Canada had reported almost one million cases of COVID-19 and about 23,000 related deaths by the beginning of April.
YELLOWKNIFE, Northwest Territories, CANADA: Delivering quality health services over long distances to small, isolated communities is an ongoing challenge ...
OCO Biomedical, based in Albuquerque, N.M., a manufacturer of dental implants and attachment systems, recently received approval from Health Canada for the ...
TULSA, OKLA., USA: AMD LASERS, a global developer and manufacturer of dental lasers and provider of dental laser education, has announced that its Picasso ...
VANCOUVER, BRITISH COLUMBIA, CANADA: It was a weekend of learning and growing at the International Congress of Oral Implantologists (ICOI) World Congress ...
MONTREAL, Quebec, CANADA: At AAE19, the annual session of the American Association of Endodontsts, held April 10 to 13, Sonendo announced it is launching ...
Over the years, dental specialties have emerged in faculties of dentistry due to the advancements within specific areas of treatment, and they have been ...
TORONTO, Ontario, CANADA: The Ontario Dental Association (ODA) is calling for the provincial government to include dentists in the early rounds of vaccine ...
Henry Schein Canada, the Canadian dental business of Henry Schein Inc., recently donated $20,000 to the Canadian Cancer Society in support of its efforts to...
AMERICAN FORK, Utah, USA: Henry Schein One, a joint venture of Henry Schein Inc., recently announced the Canadian release of Dentrix G7, the upgraded ...
MIS Implants Canada is collaborating with the University of Miami to bring to Canada the “Fellowship in Implant Dentistry” from the University ...
Live webinar
Thu. 18 July 2024
8:00 PM EST (Toronto)
Live webinar
Tue. 6 August 2024
6:00 PM EST (Toronto)
Live webinar
Tue. 13 August 2024
7:00 PM EST (Toronto)
Live webinar
Wed. 14 August 2024
12:30 PM EST (Toronto)
Live webinar
Wed. 21 August 2024
9:00 AM EST (Toronto)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (Toronto)
Live webinar
Mon. 2 September 2024
5:00 AM EST (Toronto)
To post a reply please login or register